在欧洲,GlaxoSmithKline的Shingrix shingles疫苗 获得了新的预填注射器版本 正在接受审查 GlaxoSmithKline's Shingrix shingles vaccine gets new prefilled syringe version under review in Europe.

GlaxoSmithKline的Shingrixshingles疫苗有一个新的预先填充的注射器版本,欧洲药品署正在审查该版本。 GlaxoSmithKline's Shingrix shingles vaccine has a new prefilled syringe version that the European Medicines Agency is reviewing. 美国已经批准的这种新格式简化了疫苗对保健专业人员的管理,消除了将不同组成部分混合的需要。 This new format, already approved in the U.S., simplifies the vaccine's administration for healthcare professionals by eliminating the need to mix separate components. 自2018年推出疫苗以来,欧洲已有2 500多万人获得疫苗,新版本旨在使疫苗更容易获得和方便使用。 Since its introduction in 2018, over 25 million people in Europe have received the vaccine, and the new version aims to make it even more accessible and convenient.